1. Home
  2. OTLK

OTLK

Outlook Therapeutics Inc.

Logo Outlook Therapeutics Inc.

Health Care

Biotechnology: Biological Products (No Diagnostic Substances)

Nasdaq

as 04-12-2024 4:00pm EST

$
-
.
-
-
-
$
-
.
-
-
-
-
.
-
-
%

Outlook Therapeutics Inc is a clinical-stage biopharmaceutical company focused on developing and commercializing ONS-5010, a monoclonal antibody, or mAb, for various ophthalmic indications.

Founded: 2010 Country:
United States
United States
Employees: N/A City: ISELIN
Market Cap: 221.5M IPO Year: 2016
Target Price: $46.43 AVG Volume (30 days): 648.3K
Analyst Decision: Strong Buy Number of Analysts: 9
Dividend Yield: N/A Dividend Payout Frequency: N/A
EPS: -4.00 EPS Growth: N/A
52 Week Low/High: $4.00 - $40.60 Next Earning Date: 05-13-2024
Revenue: N/A Revenue Growth: N/A
Revenue Growth (this year): N/A Revenue Growth (next year): 4491.55%

Share on Social Networks: